Adia Med ADIA
OTC ADIA
$0.13 +0.01 (+8.33%)
At close: Nov 10, 2026 · 4:00 PM EST

Adia Med (ADIA) Capital Leases (2024 - 2026)

Updated

Adia Nutrition (ADIA) recorded Capital Leases of $55,586 in Q1 2026, down 9.4% from the prior quarter.

Analysis

Adia Med (ADIA) Capital Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, Adia Nutrition reported Capital Leases of $61,387, down 30.3% from FY2024.

  • Across earlier years, Capital Leases came in at $88,030 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Adia Med 12.27 Mn 11.92 Mn 282,580.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26,784.00
Mar 31, 2026 55,586.00
Dec 31, 2025 61,387.00
Dec 31, 2024 88,030.00
API Access

Adia Med Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=ADIA&period=max&api_key=YOUR_API_KEY